RespireRx Pharmaceuticals Inc.
RSPI · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $256 | $1,034 | $750 | $391 |
| - Cash | $0 | $1 | $1 | $17 |
| + Debt | $2,709 | $2,078 | $1,684 | $1,634 |
| Enterprise Value | $2,965 | $3,110 | $2,433 | $2,008 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,651 | $139 | -$3,756 | $26 |
| % Margin | – | – | – | – |
| Net Income | -$2,103 | -$3,870 | -$4,847 | -$2,520 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.036 | -0.04 | -0.22 | -6.45 |
| % Growth | 10.5% | 81.9% | 96.6% | – |
| Operating Cash Flow | -$144 | -$956 | -$513 | -$488 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$144 | -$956 | -$513 | -$488 |